#srl diagnostics home sample collection
Text
Why SRL Home Collection
One has to choose SRL Home Collection as it helps in providing the preventive health check-up that contains a series of medical tests and procedures, that are generally undertaken to understand all the regulative measures that are needed to prevent the various diseases in the early stage. SRL Home Collection with this preventive health check-up can easily detect certain types of behaviour, infections, medical problems, or any type of habit before they become crucial. With the 25 years of accurate diagnostics, SRL Home collection is essential for all of us, no matter in which age group you are living you can get the best part of services with home collection services.
SRL Path labs provide efficient checkpoints for the immune system to regulate it, these tests are crucial test in today's life as it prevents the immune system from attacking the cells that are indiscriminate. To evaluate the different conditions as per the prevailing diseases and disorders, you will get the services from SRL path labs. It also provides the health report of a particular person that helps to bring clarity to health and medical issues from political, social, or scientific points of view.
SRL Blood test along with other services supplies the regular blood test check-up, which is an important way to keep track of their well-being. So getting test regularly assist you in visualizing the changes that you should be adopted that undergo as per your age and that also empowers you to make an informed decision well in advance so you will not affect your health in any way. To get the overall picture of your health and well-being, you shall take the services of a regular blood test at SRL Home collection. This test helps you in naming the signs of an illness that in turn avoids the progression to reach several stages. SRL collection Centre collects the blood that has been collected through the samples blood and measures all the components including RBC, WBC, and platelets to get the early results. Early diagnosis of any disease always offers prevention against the progression.
#SRL Home collection#SRL path lab#SRL blood test#SRL Home Visit#SRL Pathology Lab#SRL Lab Near me#SRL Diagnostics Centre#SRL Lab South Delhi#SRL Collection Centre#SRL Home Collection Services#srl home collection near me#srl path lab south delhi#srl diagnostics home sample collection#SRL Lab Delhi#SRL diagnostics delhi#srl diagnostics home collection delhi#srl diagnostics near me#SRL lab home Sample collection
0 notes
Text
How path labs of SRL performed
SRL path lab provide the services of diagnostic and related healthcare tests in India through the integrated network as the company offers patients and healthcare providers a broad range of services that are used in the core field of testing with the diagnosis of patients and also prevents the monitoring and treatment of diseases with other health conditions. SRL lab south delhi have also built a national level hub and spoke network that also includes the national reference laboratory with references lab and other clinical laboratories with different kinds of patient service centers. Its customers include individual patients hospitals and other health care providers with their corporate customers.
The catalog of services includes so many test panels and pathology tests with radiology and cardiology tests. This business of diagnostic and healthcare test services continues to be provided by the SRL Path labs. A qualified team of professionals with specialized degrees works with the SRL Collection Centre and it works as a growing pool of leaders that are from top institutions.
We believe in the fact that we focus on providing quality to patients and are also capable of performing a sustainable network with all the services currently provided by the physicians. Our network of SRL path lab South Delhi has coverage all across India including metropolitan cities. We offer the access to best pathology diagnostic labs in India. By delivering the most accurate reports over so many years, SRL path labs have gained a reputation among the most trustworthy and reliable labs of pathology.
SRL lab Delhi are considered certified pathology labs and it is among the top few laboratories that are also accredited by the Pathologist Organisation with the certification. Despite the size of SRL path labs, we also maintain the environment that helps in nurturing the top thinkers in India with their respective fields of expertise.
#SRL Path lab#SRL Home Collection#SRL Pathology Lab#SRL Lab Near me#SRL Diagnostics Gurgaon#SRL Lab South Delhi#SRL Home Collection Services#srl home collection near me#srl diagnostics home sample collection#SRL Lab Delhi#SRL Home collection#SRL path lab#SRL blood test#SRL Home Visit#SRL Diagnostics Centre#SRL Collection Centre#srl path lab south delhi#SRL diagnostics delhi#srl diagnostics home collection delhi#srl diagnostics near me#SRL lab home Sample collection
0 notes
Text
Asia-Pacific DTC Laboratory Testing Market to be Worth $1.58 Billion by 2030
Meticulous Research®, a prominent market research firm, released a report titled, 'Asia-Pacific DTC Laboratory Testing Market by Application (Genetic Testing {Ancestry, Disease Risk [Cancer, Cardiac, Neurological], Carrier Status}, Diabetes, COVID, Routine, Thyroid), and Sample Type (Blood, Saliva, Urine) - Forecast to 2030.’
According to the latest report by Meticulous Research®, the Asia-Pacific direct-to-consumer (DTC) laboratory testing market is anticipated to achieve a value of $1.58 billion by 2030, with a compound annual growth rate (CAGR) of 12.8% from 2023 to 2030. The market's expansion is attributed to various factors, including the increasing prevalence of chronic and sexually transmitted diseases, higher disposable incomes, heightened consumer awareness, growing emphasis on personal health management, and the advantages offered by DTC laboratory testing such as convenience, affordability, and accessibility. Additionally, factors like the rising healthcare costs, aging population, expanding telehealth adoption, and the increasing utilization of pharmacogenomic testing in DTC laboratory testing present opportunities for market growth, particularly in emerging economies.
Challenges facing the Asia-Pacific DTC laboratory testing market include concerns regarding genetic data privacy, potential misinterpretation of test results, and insufficient access to professional medical guidance. Additionally, obstacles like sample integrity and interference problems, regulatory issues, absence of reimbursement, and a narrower range of tests available compared to traditional laboratory testing serve as constraints on market expansion.
Key Players
The Asia-Pacific DTC laboratory testing market report features profiles of prominent players such as Metropolis Healthcare Limited (India), SRL Limited (India), Hirotsu Bio Science (Japan), Mapmygenome India Limited (India), Genesis Healthcare Co. (Japan), Augmentum Diagnostics (India), Apollo Health and Lifestyle Limited (India), WeGene (China), GeseDNATechnology LLP (China), Laboratory Corporation of America Holdings (U.S.), LetsGetChecked, Inc. (U.S.), and 23andMe Holding Co. (U.S.)
The Asia-Pacific DTC laboratory testing market is segmented based on Application (Genetic Testing [Ancestry/Genealogy, Disease/Risk Assessment {Cancer, Cardiovascular Diseases, Neurological Diseases, Other Diseases}, Carrier Status, Other Genetic Tests], Diabetes Testing, Routine Clinical Testing, Thyroid Function Testing, Sexually Transmitted Disease Testing, Other Applications), Sample Type (Blood, Saliva, Urine, Other Samples) and Geography. The report also assesses competitors in the industry and examines market trends at regional and country levels.
Among applications, in 2023, the genetic testing sector is forecasted to dominate the market, primarily due to the growing interest in DTC genetic testing for exploring family health history and disease risk assessment. The segment's prominence is further fueled by the introduction of new DTC genetic tests catering to various applications and the heightened curiosity among individuals, especially in developed nations, to delve into their ancestry and lineage.
Among sample types, the blood segment is projected to hold the majority share of the market, primarily due to the extensive range of tests utilizing blood samples. Factors contributing to the segment's dominance include the high reliability of results, growing incidence of chronic diseases, heightened consumer awareness regarding chronic disease monitoring, and the convenience offered by at-home blood collection services.
Geographic Review
The research report examines significant Asia-Pacific regions, including China, Japan, India, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, the Philippines, Vietnam, and the rest of the Asia-Pacific. In 2023, China is projected to dominate the Asia-Pacific DTC laboratory testing market, primarily due to its sizable consumer base, rising disposable income, and increasing awareness of personal health management.
Download Sample Report Here @ https://www.meticulousresearch.com/pressrelease/908/asia-pacific-dtc-laboratory-testing-market-2030
Key questions answered in the report:
What are the market segments experiencing notable growth in terms of Asia-Pacific DTC laboratory testing concerning application, sample type, and geographical location?
What was the past performance of the DTC laboratory testing market in the Asia-Pacific region?
What are the projected market predictions and estimations for the timeframe spanning from 2023 to 2030?
What are the primary factors fueling growth, hindering progress, presenting potential avenues, and posing obstacles in the Asia-Pacific DTC laboratory testing market?
Who are the key players in the Asia-Pacific DTC laboratory testing market?
How is the competitive scenario structured, and which companies are leading the Asia-Pacific DTC laboratory testing market?
What are the latest advancements or updates in the Asia-Pacific DTC laboratory testing market?
What are the various approaches employed by leading players in the Asia-Pacific DTC laboratory testing market?
What are the patterns observed in different regions and which regions or countries are experiencing significant growth in the Asia-Pacific DTC laboratory testing market?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
#AsiaPacific#DTCLaboratoryTestingMarket#DirecttoConsumerLaboratoryTesting#DirecttoConsumerTests#PatientDirectedTesting#ConsumerInitiatedTesting
0 notes
Text
Agilus Diagnostics IPO Date, Price, GMP, Company profile, financials & risks: Dec 23
New Post has been published on https://wealthview.co.in/agilus-diagnostics-ipo/
Agilus Diagnostics IPO Date, Price, GMP, Company profile, financials & risks: Dec 23
Agilus Diagnostics IPO: Agilus Diagnostics Limited, formerly known as SRL Limited, is a leading diagnostics service provider in India. It boasts the largest network of laboratories in the country, offering a comprehensive range of tests across various specialties. Agilus operates in a rapidly growing Indian diagnostics market, fueled by rising healthcare awareness, increasing disposable income, and an aging population.
Agilus Diagnostics IPO Key Details:
Offer type: Offer for Sale (OFS) by existing shareholders (International Finance Corporation, NYLIM Jacob Ballas India Fund III LLC, and Resurgence PE Investments Ltd) – no fresh capital being raised by the company.
Issue Dates: Yet to be announced.
Offer Size: Up to 142.3 million equity shares.
Price Band: Not yet determined.
Recent News Updates:
Agilus filed its Draft Red Herring Prospectus (DRHP) with SEBI in September 2023, seeking approval for the IPO.
The company reported a consolidated revenue of Rs 1,347 crore for FY23, down from Rs 1,604 crore in FY22. However, profitability remained relatively stable at Rs 116 crore, suggesting potential resilience.
The Indian diagnostics market is projected to reach USD 27 billion by 2026, providing significant growth opportunities for Agilus.
Agilus Diagnostics IPO: Offer Details
Securities Offered:
This is an Offer for Sale (OFS) by existing shareholders. Therefore, no new securities (equity shares, bonds, etc.) will be issued by Agilus Diagnostics Limited. Existing shareholders, namely International Finance Corporation, NYLIM Jacob Ballas India Fund III LLC, and Resurgence PE Investments Ltd, will be offloading a portion of their holdings through the IPO.
Reservation Percentages:
The specific reservation percentages for different investor categories are yet to be finalized by the Securities and Exchange Board of India (SEBI). However, the typical distribution in Indian IPOs follows this pattern:
Retail Individual Investors (RIIs): 35%
Qualified Institutional Buyers (QIBs): 50%
Non-Institutional Investors (NIIs): 15%
The final percentages might vary depending on regulatory requirements and investor demand.
Minimum Lot Size and Investment Amount:
The minimum lot size for the IPO, which determines the number of shares you can subscribe to in a single application, will be announced closer to the issue date. It is typically set at a level affordable for retail investors, ranging from 100 to 200 shares.
The minimum investment amount will depend on the minimum lot size and the final issue price, which are yet to be confirmed. For example, if the minimum lot size is 100 shares and the issue price is Rs 100 per share, then the minimum investment amount would be Rs 10,000 (100 shares * Rs 100).
Agilus Diagnostics Limited Company profile:
History and Operations:
Founded in 1995, Agilus boasts a rich legacy of over 28 years in the Indian diagnostics landscape.
Initially known as SRL Limited, it rebranded to Agilus Diagnostics in 2023.
Operates a vast network of over 413 laboratories spread across 25 states and 5 union territories in India, as of March 2023.
Offers a comprehensive range of diagnostic tests catering to various medical specialties, including pathology, biochemistry, microbiology, immunology, and genetics.
Provides services directly through its own labs, partnerships with hospitals and clinics, and home sample collection facilities.
Market Position and Market Share:
Ranked second in terms of revenue from operations among diagnostic companies in India for Fiscal 2023 (Source: CRISIL Report).
Holds the title of India’s largest chain of diagnostic laboratories by geographic presence (Source: Agilus Diagnostics website).
As of March 2023, boasts the largest network of NABL accredited laboratories in India with 43 accredited labs (Source: CRISIL Report).
Prominent Brands, Subsidiaries, and Partnerships:
The “SRL” brand still enjoys strong recognition in many regions, even post-rebranding.
In April 2023, acquired Lifeline Laboratory, a reputed player in Delhi NCR, further strengthening its reach.
Partners with various hospitals and clinics across India to provide diagnostic services within their premises.
Key Milestones and Achievements:
Pioneered the concept of standardized and affordable diagnostic services in India.
Achieved significant growth through organic expansion and strategic acquisitions.
Awarded prestigious certifications like NABL for its labs, demonstrating commitment to quality standards.
Recognized for its contribution to healthcare by various industry bodies and publications.
Competitive Advantages and Unique Selling Proposition (USP):
Vast network: Reaches a broader patient base, providing accessibility and convenience.
NABL accreditation: Ensures high-quality and reliable diagnostic tests.
Comprehensive service range: Caters to diverse medical needs under one roof.
Technology focus: Implements cutting-edge technology for accurate and efficient testing.
Strong brand recognition: Builds trust and customer loyalty.
Future Growth Prospects and Earnings Drivers:
Market growth: The Indian diagnostics market is projected to reach USD 27 billion by 2026, offering substantial growth potential for Agilus.
Expansion plans: The company aims to expand its network further, targeting geographically under-penetrated areas and strategic acquisitions.
Focus on preventive care: Increasing awareness of preventive healthcare is expected to drive demand for diagnostic services, benefiting Agilus’ comprehensive offerings.
Technology adoption: Continued investment in automation and advanced testing technologies will improve efficiency and attract tech-savvy customers.
Potential Risks and Concerns for Agilus Diagnostics IPO:
Investing in any IPO, including Agilus Diagnostics Limited, involves inherent risks that investors should carefully consider before making a decision. Here are some key areas of concern:
Industry Headwinds:
The Indian diagnostics industry faces potential challenges like regulatory changes, pricing pressures from government healthcare initiatives, and competition from new players. These factors could affect Agilus’ growth and profitability.
Company-Specific Challenges:
While Agilus boasts a strong network and financial position, there are some aspects to consider:
The recent revenue decline raises questions about future growth momentum.
Reliance on existing tests might limit diversification and exposure to newer, high-growth segments.
Integration of acquired entities like Lifeline Laboratory needs careful management to maintain operational efficiency.
Financial Health:
Although debt-free, Agilus’ financial performance in FY23 showed a revenue decline. The final P/E ratio after the issue price is determined will be crucial to assess valuation and potential risks.
Investors should thoroughly analyze the company’s financial statements and future projections provided in the DRHP before making a decision.
Red Flags:
Any unexpected negative news about the company or the industry during the pre-IPO or listing period could raise red flags and impact investor sentiment.
A significantly high GMP compared to industry benchmarks might indicate unrealistic expectations and potential for price correction after listing.
Agilus Diagnostics Limited Draft Offer Documents filed with SEBI
Also Read: How to Apply for an IPO?
#Allotment Details#Company Profile#Financial Performance#Investment#IPO date#Lot Size#UPCOMING IPO#IPO#News
0 notes
Text
Dr blaylock wellness report reviews
#Dr blaylock wellness report reviews verification
#Dr blaylock wellness report reviews professional
#Dr blaylock wellness report reviews free
Poor back-end operations and poor support Please let us know your order number at and we promise to get this resolved quickly. We are very sorry to know about your experience with us.
#Dr blaylock wellness report reviews professional
This is my second such experience and I feel other platforms are much more professional spcly in things like meds and all. But unfortunately what best suggestions they gave is that they have processed refund and when I insisted that rather than refund I need meds which are required there is no solution or even empathy from their side. Upon writing continually for another 24 hours over mail, I somehow be able to get connected to their customer care. But on delivery date without any confirmation or even a call the medicine was mentioned as delivered to me. I wish I could give some thing less than 1, if possible a zero or minus. Incorrectly Product Mentioned Delivered, Poorest Possible Customer Servcie The information SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. HealthKit: To allow you to sync your fitness data with Tata 1mg for BMI calculation & tracking of walking steps, so we can personalize your daily goals & show you the progress in StepUpĭOCTOR-PATIENT RELATIONSHIP: Tata 1mg does not replace your relationship with a physician or healthcare provider. Location: To know about your current location & show you the services available in your area Photos/Media/Files: To store & retrieve your uploadsĬamera: To allow you to take a photo & directly upload it to the app * We have been selected as the only company from across the globe for SD#3 "Health & Well Being for all" by Unreasonable Group, US State Department * We were also recognized by the Government of India - Ministry of Health & Family Welfare as an m-health initiative that consumers can use.
IMC Awards for Excellence, 2019 for ‘Best Mobile Innovation for Health’.
ĚBP News 'Healthcare Leadership Award’ at World Marketing Congress, 2019.
VC Circle Award for the "Most promising Healthcare startup.
India's only ISO/IEC 27001 & LegitScript certified online healthcare platform.
Top 50 venture in The Smart CEO-Startup50 India.
ěML Munjal Award for 'Business Excellence through Learning & Development'.
We have been conferred with prestigious titles like: We set out on our journey in 2015 & have come a long way since. Our goal is to make healthcare understandable, accessible & affordable. Get useful health tips written by expert doctors like Ayurveda & its benefits, maintaining personal hygiene, & other relevant topics. Access other medicine information like treatment, usage, side effects, recommendations, safety warnings, expert advice & answers to patient FAQs. We provide accurate, authoritative & trustworthy information on medicine to help people use their medicines safely.
#Dr blaylock wellness report reviews verification
Doctors registered on Tata 1mg undergo a strict onboarding and verification process. Find doctors & book appointments with General Physicians, Gynaecologists, Dermatologists & more specialities. Chat privately with registered medical specialists. Tata 1mg allows you to consult doctors online from home.
#Dr blaylock wellness report reviews free
Get free home sample-collection & online reports. Book from over 2,000 tests by 120+ top verified labs such as Dr Lal Path Labs, SRL Diagnostics, Thyrocare & more via Tata 1mg. Test samples are collected by highly trained & experienced phlebotomists. Get tested safely from home & get best discounts on blood tests, thyroid tests, diabetes tests & more. All products sold are 100% genuine and procured from verified & licensed pharmacies only.ĭon't want to go through the hassle of adding each medicine separately? Just upload prescription on the app & we'll place the order for you. Tata 1mg is a one-stop destination for Homeopathy & Ayurvedic medicines, medical devices, health supplements, personal hygiene products & brands like Dabur, Himalaya, SBL Homeopathy, Accu-Chek & more. There are 2 lakh+ allopathy medicines available at best prices on our medicine app.
Get health tips & educational content from experts.
Get medicine information vetted by doctors.
ěuy genuine medicines & health products.
Order medicines online & get same-day safe delivery at home in select cities. We are active in 1000+ cities including Delhi NCR, Mumbai, Pune, Bangalore, Kolkata & more. Be it medicines, health products, medicine info, lab tests, doctors consultation, the Tata 1mg app provides it all. Tata 1mg is India's leading & most trusted healthcare platform.
0 notes
Video
youtube
SRL Diagnostic Lab offers you Blood test sample collection at home. They are professionals and provide accurate reports. They will be at your door step a cording to your convenience. SRL Diagnostic Labs offers various blood tests, so you don't have to worry about going to different places for that.
1 note
·
View note
Text
srlhomecollect
About us: SRL Path Lab - We are leading pathology offering affordable blood testing services. We at SRL Home Collection provide quality lab testing at your comfort. Hassle free home sample collection services will help you test done from your doorstep. SRL Path Lab – SRL Diagnostics Center in Delhi
#SRL home collection#SRL path Lab#SRL Blood Test#SRL Home Visit#SRL Pathology Lab#SRL Lab Near me#SRL Diagnostics Centre#SRL Lab
0 notes
Text
SRL Home Collection Services - Leading Diagnostics Centre offering affordable blood testing services and home sample collection services for quality blood testing. Authorized Collection partner of SRL Diagnostics. We are offering home based blood testing services with Covid-19 safety and contactless equipment. SRL Path Lab is India's leading laboratory with NABL Certified
1 note
·
View note
Link
Fsh Follicle Stimulating Hormone cost in Amritsar
SRL Diagnostics
Pan India
Certified By: NABL ,CAP
54 lab tests booked this week
Fsh Follicle Stimulating Hormone test cost starts at Rs 480. The test is available from 1 diagnostic centers in amritsar. You can avail discount from 20% - 50%. Bookmerilab helps you in saving up to Rs. 480 on Fsh Follicle Stimulating Hormone in amritsar. This test is also known as ,. You can also avail free home sample collection services or choose a diagnostic center near by.
Thyrocare in Mumbai
Thyrocare in Delhi
Thyrocare in Bangalore
Thyrocare in Hyderabad
Thyrocare in Ahmedabad
Thyrocare Nashik
Thyrocare Faridabad
0 notes
Text
Global Blood Collection Tube Market
Global Blood Collection Tube Market Size, Share, Growth, Industry Trends and Forecast 2020-2030
The blood collection tube market has shown the growth of USD 5.1 billion in 2020 and is expected to grow by USD 8.8 billion by 2030, at an approximate CAGR of 5.7% during the forecasted period.Blood collection tubes are the devices that are used for collecting blood samples for performing laboratory diagnostic tests and treating patients. These devices are being used for specific cases like cancer therapies, accident victims, blood transfusions or transplantation and during the critical surgeries. The major uses of these tubes like in clinics, hospitals, blood banks, pathology laboratories, and multi-specialty hospitals have shown good growth and are expected to grow at a higher CAGR growth during the forecasted period.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020179
Market Dynamics and Factors:
The increasing numbers of diseases like a growing number of surgeries, accidental, road accidents, sports injuries, and trauma are the prevailing factors for the growth of the blood collection tubes. Owing to the high costs of automated blood collection devices that costs between USD 1,000 and USD 3,000 have restrained the market growth. Technological advancements in blood collection procedures and products for critical diseases like Difficult Venous Access (DVA) have reduced the complicated procedures and further infection to cause amenia has given the opportunity to the growth of blood collection tubes. The lack of skilled professionals for operating advanced automated blood collecting devices will aff et the market growth in the future.
Market Segmentation:
Global Blood Collection Tube Market – By Product
Serum Tube
Plasma Tube
EDTA
Heparin
Coagulation
Glucose
Needle
Lancet
ESR
Syringe
Blood Bag
Global Blood Collection Tube Market – By Application
Hospital
Blood Bank Center
Academics
Home Care
Global Blood Collection Tube Market – By Method
Manual
Automated
Global Blood Collection Tube Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020179
Geographic Analysis:
North America is the largest market and is also expected to dominate the market of global blood collection tube due to growth in the levels of awareness, advancements in blood collection technologies, rising prevalence of blood disorders, increasing demand for plasma from biopharmaceutical companies for plasma fractionation, government support, rising demand for apheresis initiatives for blood safety, and increasing prevalence of lifestyle diseases such as diabetes. The increasing adoption of automated blood collection devices has shown a boost in the North America region. For example, in 2015, according to the American Diabetes Association, 30.3 million people in the U.S. had diabetes which is 9.4 % of the total population. Moreover, countries such as India and China in the Asia Pacific region are expected to be the fastest-growing markets in this region owing to a large population base, improving healthcare infrastructure, increasing the number of hospitals, and growing medical tourism.
Competitive Scenario:
The major key players in the global blood collection tube market are Abbott, Biosigma, Becton, Dickinson & Company, Greiner Group AG, Sarstedt AG & Co., QIAGEN N.V., Terumo Corporation, and FL Medical SRL.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020179
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Blood Collection Tube industry, although key threats, opportunities and disruptive technologies that could shape the Global Blood Collection Tube Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Blood Collection Tube Market most.
The data analysis present in the Global Blood Collection Tube Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Blood Collection Tube Market business.
The 2021 Annual Global Blood Collection Tube Market offers:
100+ charts exploring and analysing the Global Blood Collection Tube Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Blood Collection Tube Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020179
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/
0 notes
Text
How SRL home visit plays role
With the rising fear of so many diseases, SRL Home Visit brings healthcare services to the most convenient and also from a safety point of the home environment is the most viable situation. The advancement in modern technology that is updated day to day has also become a boon to this situation.
SRL home visit service is one the service that also brings in professional medical service from the comfort of your home. It is one of the services that have breakthroughs in home health care services also. The medical services that are provided at home itself are now fairly common with lots of advantages as well. There are so many reasons why seeing a doctor at home is best and preferable to going to a clinic or hospital. There are so many types of doctors that provide consultation services that are available for families. These services are perfectly woven to meet the needs of patients by giving the proper attention that a patient deserves.
There are so many emergency cases also, in which the patient can directly call the doctor in their comfort zone for health consultation and treatment. In hospitals, normally people don’t want to stand in a long queue which might be non-convenient in cases where the patients are weak and vulnerable. SRL Home visit helps to make an appointment with doctors that can also help in getting exposed to various viruses and infections. When any doctor examines the patients in the comfort of their home, they feel more at ease. These visits are also more personalized than the care that most patients receive in hospitals. Even the doctors can assess better as they get a complete understanding of all of your surroundings as well. With that, they are also less distracted because you will the only patient at home visit and therefore you get the undivided attention.
#SRL Home collection#SRL path lab#SRL blood test#SRL Home Visit#SRL Pathology Lab#SRL Lab Near me#SRL Diagnostics Centre#SRL Lab South Delhi#SRL Collection Centre#SRL Home Collection Services#srl home collection near me#srl path lab south delhi#srl diagnostics home sample collection#SRL Lab Delhi#SRL diagnostics delhi#srl diagnostics home collection delhi#srl diagnostics near me#SRL lab home Sample collection
0 notes
Text
How SRL collection centre works
SRL collection Centre works with so many health care providers that may be unfamiliar with the workings of the laboratory of pathology. SRL path lab initiates a very complex series of events that results in a pathologic interpretation and diagnosis. There are so many pathologic evaluations of tissues that provide information on the SRL path lab.
This works with the key objectives of the importance of a pathology laboratory. While checking the importance of pathologic examination, it could be seen that diagnosis of cancer is not easily or conclusively established nor it is assumed safely. There is so many policies framework that works with supporting practices and they are well written into the by-laws of most of the hospitals with this they are regularly monitored by the hospital committees and agencies.
SRL blood tests are used to measure or examine proteins, cells, chemicals, and other substances. Blood testing is sometimes known as blood work, as it is one of the most common types of lab tests also. This is also included as a part of the regular check-up and an SRL blood test is used to help diagnose certain kinds of conditions and diseases. It helps in monitoring the most chronic conditions and diseases like if someone has a high level of cholesterol or diabetes.
SRL blood tests have some other types like Complete Blood Count, known as CBC which measures the different parts of the blood including the red blood cells and white blood cells as well as hemoglobin and platelets. A health care provider in SRL Path Lab will need to take a sample of blood, that’s called a blood draw. When this is taken from any vein, this is then known as venipuncture. A lab professional who works in SRL Path Lab known as a phlebotomist helps in taking the blood sample from a vein in your arm.
#SRL Path lab#SRL Home Collection#SRL Pathology Lab#SRL Lab Near me#SRL Diagnostics Gurgaon#SRL Lab South Delhi#SRL Home Collection Services#srl home collection near me#srl diagnostics home sample collection#SRL Lab Delhi#SRL Home collection#SRL path lab#SRL blood test#SRL Home Visit#SRL Diagnostics Centre#SRL Collection Centre#srl path lab south delhi#SRL diagnostics delhi#srl diagnostics home collection delhi#srl diagnostics near me#SRL lab home Sample collection
0 notes
Text
Rapid Oral Fluid Screening Devices Market Competitive Dynamics & Global Outlook 2021-2029
The Global Rapid Oral Fluid Screening Devices Market 2021-2029 Report provides an in-depth analysis on the studied market that helps to seem at the longer term requirement also as prediction. The Rapid Oral Fluid Screening Devices Market Report evaluates the market by key market players, opportunities, value, trends, growth, market share, market competition landscape, recent developments and sales volume analysis. Additionally, it magnifies the chance for decision-making and helps create an efficient counter-strategy to realize a competitive advantage. The report provides up-to-date review of the present global market scenario, the newest developments and drivers, and therefore the overall market environment is given within the study.
Free Sample Report + All Related Graphs & Charts @ https://www.factomarketinsights.com/sample/596
It provides the impact and recovery of Covid-19 pandemic on the rapid oral fluid screening devices Market. Relevant statistical data is additionally provided within the report back to recognize the challenges caused by the outbreak of Covid-19 and methods to cope up with the present scenario.
In addition to the present, the report also covers the section of competitive landscape of the worldwide market, which incorporates the market share & positioning of all the leading players within the industry. The competitive landscape analysis provides in-depth analysis of the company’s business and performance including company overview, recent investments by top players, financial information of market players, business strategy, revenue breakup by segment and by geography, SWOT Analysis, key product offering, marketing and distribution strategies, new development. a neighborhood of recent news & development has been added to the report which covers the newest information that are related with the market covering the acquisition, expansion, technology development, research & development activities, and other market activities.
Obtain Report Details @ https://www.factomarketinsights.com/report/596/rapid-oral-fluid-screening-devices-market
The Following are the Key Features of Global Aluminium Trays Market Report:
Market Overview, Industry Development, Market Maturity, PESTLE Analysis, Value Chain Analysis
Growth Drivers and Barriers, Market Trends & Market Opportunities
Porter’s Five Forces Analysis & Trade Analysis
Market Forecast Analysis for 2020-2029
Market Segments by Geographies and Countries
Market Segment Trend and Forecast
Market Analysis and Recommendations
Price Analysis
Key Market Driving Factors
Rapid Oral Fluid Screening DevicesMarket Company Analysis: Company Market Share & Market Positioning, Company Profiling, Recent Industry Developments etc.
Global Rapid Oral Fluid Screening DevicesMarket Segmentation Analysis:
Rapid Oral Fluid Screening Devices Market, by Product Type:
1- Panel Saliva Drug Test Kits
4- Panel Saliva Drug Test Kits
5- Panel Saliva Drug Test Kits
6- Panel Saliva Drug Test Kits
7- Panel Saliva Drug Test Kits
8- Panel Saliva Drug Test Kits
9- Panel Saliva Drug Test Kits
10- Panel Saliva Drug Test Kits
12- Panel Saliva Drug Test Kits
Rapid Oral Fluid Screening Devices Market, by Form Type:
Cassettes
Swabs
Strips
Rapid Oral Fluid Screening Devices Market, by Drug Type:
Alcohol
Marijuana (THC)
Opioids
Cocaine
Amphetamines
Methamphetamines
Benzodiazepines
Others
Rapid Oral Fluid Screening Devices Market, by End User:
Hospitals
Diagnostic Laboratories
Forensic Laboratories
Private Employers
Home Care Settings
Regional Insights:
The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the regions are fragmented into the country and regional groupings:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa)
Reasons to purchase the report:
Identify possible investment areas supported a comprehensive analysis of the worldwide rapid oral fluid screening devices Market over subsequent few years.
Gain in-depth knowledge of the underlying factors that drive demand for rapid oral fluid screening devices Market and recognize the opportunities provided by them.
Strengthen the business knowledge in terms of industry dynamics, demand drivers, and therefore the latest technological advances among others.
Identify the main channels that drive the demand for rapid oral fluid screening devices Market, offering a robust image of potential prospects which will be tapped, leading to growth in revenue.
Channelize funds by concentrating on the continued initiatives pursued by the various countries within the global rapid oral fluid screening devices Market.
Competitive Analysis:
The key players of the market are listed during this section of the study. It helps to know the tactics and alliances that players consider fighting market rivalry. An important microscopic check out the market is given within the detailed study. The major players operating in the Global rapid oral fluid screening devices Market are
Abbott Laboratories
Guangzhou Wondfo Biotech Co., Ltd
OraSure Technologies, Inc
Oranoxis Inc
Premier Biotech, Inc
UCP Biosciences, Inc.
SCREEN ITALIA SRL
Securetec Detektions-Systeme AG
MEDACX Ltd.
AccuBioTech Co. Ltd
Interested to Procure The Data? Inquire here at @ https://www.factomarketinsights.com/enquiry/596
About Us:
Facto Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on industries, companies, products, and trends.
Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500 companies and leading advisory firms.
Contact Us:
Facto Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (518) 250-1215
Email:[email protected]
Website: www.factomarketinsights.com
0 notes
Text
Govt Technical Officer Recruitment – Biotech & Life Sciences Job Vacancy
New Post has been published on https://biotechtimes.org/2020/10/22/govt-technical-officer-recruitment-biotech-life-sciences-job-vacancy/
Govt Technical Officer Recruitment – Biotech & Life Sciences Job Vacancy
JSACS Govt Technical Officer Recruitment
Govt Technical Officer Recruitment – Biotech & Life Sciences Job Vacancy. Govt. of Jharkhand has announced vacancies in the Jharkhand State AIDS Control Society. Govt Technical Officer Recruitment. Interested Biotech & Life Sciences candidates can apply as per the instructions given below:
Govt. of Jharkhand
Jharkhand State AIDS Control Society
Dept. of Health & Family Welfare
Sadar Hospital Campus, Purulia Road, Ranchi
Jharkhand State AIDS Control Society, Department of Health & Family Welfare, Government of Jharkhand invites applications from suitable candidates for (A) Technical Officer (TO) & Lab Technician positions in Viral Load Lab (VL Lab) (B) Technical Officer (TO) & Lab Technician positions in State Reference Laboratories (SRL). The positions would be purely contractual in nature. Details for the Govt Technical Officer Recruitment posts are as follows:
Post-I
Name of the Position: Technical Officer, Viral Load Lab, RIMS, Ranchi
Number of posts: 01
Remuneration per month: Rs.30,000/-
Qualification & Experience
M.Sc. in medical Virology/ microbiology/ Biotechnology/ Life Science.
Minimum two years experience in Molecular Diagnostic Laboratory or another laboratory/
Candidates with experience of working in NABL accredited or applied lab will be preferred
Post-II
Name of the Position: Technical Officer, SRL, RIMS, Ranchi
Number of posts: 01
Remuneration per month: Rs.25,000/-
Qualification & Experience
1. Medical graduate with two-year laboratory experience
2. M.Sc. in medical microbiology/ Biotechnology/ Life Science
Minimum two years experience in medical microbiological/ immunological laboratory techniques
Candidates with experience in quality assurance will be preferred
Post-III
Name of the Position: Technical Officer, SRL, PMCH, Dhanbad
Number of posts: 01
Remuneration per month: Rs.25,000/-
Qualification & Experience
1. Medical graduate with two-year laboratory experience
2. M.Sc. in medical microbiology/ Biotechnology/ Life Science
Minimum two years experience in medical microbiological/ immunological laboratory techniques
Candidates with experience in quality assurance will be preferred
Post-IV
Name of the Position: Technical Officer, SRL, MGMMCH, Jamshedpur
Number of posts: 01
Remuneration per month: Rs.25,000/-
Qualification & Experience
1. Medical graduate with two-year laboratory experience
2. M.Sc. in medical microbiology/ Biotechnology/ Life Science
Minimum two years experience in medical microbiological/ immunological laboratory techniques
Candidates with experience in quality assurance will be preferred
Post-V
Name of the Position: Lab Technician, Viral Load Lab, RIMS, Ranchi
Number of posts: 01
Remuneration per month: Rs.20,000/-
Qualification & Experience
B.Sc. Biotechnology /graduate in Medical Laboratory Technology/Diploma in Medical Laboratory Technology (DMLT).
1-year experience in a molecular diagnostic laboratory for Graduate in Science
2 years experience in molecular diagnostic laboratory for those with diploma in MLT Candidates with experience of working in NABL accredited or applied lab will be preferred.
Terms of Reference
Technical Officer, Viral Load Lab
1) Routinely perform Viral Load testing
2) Develop SOP and other relevant documents for NABL
3) Support development and implementation of Quality Management System in the VL lab
4) Follow SOPs and forms of the VL laboratory and as defined
5) Report generation and dispatch within the turnaround time
6) Ensure all documentation as per the National guidelines
7) Analyze lab data including program data and QC data
8) Ensure participation of lab in EQAS programme
9) Supervisory role for troubleshooting, root cause analysis of testing errors at the lab
10) Monitor quality indicators as per lab quality policy
11) Perform trainings on sample collection and transportation for linked sites.
12) Ensure maintenance of all samples for sample repository for later evaluation.
13) Ensure confidentiality of specimen at all levels.
14) Will be accountable for every report generated by lab
15) To attend all training/meeting organized by NACO/ SACS
16) To enter data in IMS
17) Visit to ART centre to monitor and review the work related to viral load sample collection by MHL
18) Submission of certified statement of expenditure at periodicity defined by SACS
19) Submission of monthly testing report to NACO
20) Coordination with SACS and NACO for lab consumables, kits and other things for smooth functioning of lab
21) Perform any other duties as assigned by Lab in-charge and SACS.
Technical Officer, SRL
1.) Supervisory and trouble-shooting, root cause analysis of testing errors in ICTCs under SRL.
2.) Supervision and mentoring of laboratory technicians of ICTCs/PPTCTS through on site visits
3.) Monitor the work-related to EQAS, including sending of panesl to the ICTCs/PPTCT/blood banks. EQAS data analysis and reporting.
4.) Organizing ICTC-LT training
5.) Submission of monthly testing report to NACO
6.) Twelve days tour to linked ICTC centers (Tour report has to be submitted within 48 hours to I/C SRL and copy to NACO)
7.) Prepare SOPs and documents for accreditation
Lab Technician, Viral Load Lab
1) Routinely perform viral load testing
2) Assist TO in development of technical SOPs
3) Assist TO in documentation as per National viral load guidelines
4) Ensure maintenance of all samples for sample repository for later evaluation
5) Ensure that samples in the repository will not be used for research purpose
6) Ensure maintenance and calibration of automated equipment
7) Ensure not to undertake any independent testing other than NACO samples
8) Ensure confidentiality of specimen at all levels.
9) Will have shared accountability with TO for every report generated by lab.
10) To enter data in IMS
11) Timely dispatch of reports to ART centers
12) To attend all training organized by NACO/ SACS
13) Assist TO in organizing and performing trainings on sample collection and transportation for linked sites
14) Perform any other duties as assigned by Lab in-charge and SACS
How to Apply
1. Candidate will find the whole advertisement at bottom left side as Latest Recruitment of the http://recruitment.jharkhand.gov.in.
2. Candidate has to register herself/himself on recruitment portal using Register tab on the Home page of http://recruitment.jharkhand.gov.in .For which the whole process flow has been attached as Annexure-I
3. After successful online payment candidate will get payment receipt and his/her application process will be completed. Candidate should keep safely his/her Application Request ID and password.
4. For any difficulty send e-mail on [email protected] at least day before closure of application deadline i.e. …02/11/2020……………………till 05:00PM.
Note:
1. The appointment of professionals will be purely on contract basis for a period of one (1) year, which may be extended after the annual review of performance, output and desired impacts. However, the contract may be terminated in the case of unsatisfactory service.
2. The successful candidate will have to sign a contractual agreement.
3. The contract shall not confer any rights or claim of extension/ absorption in the department. The candidate will have to produce an affidavit in the case.
4. These are all posts for district level.
5. The remuneration will be paid as per NACO norms/ order/ guidelines.
6. Request for transfer will not be entertained and subsequently contract may be terminated.
7. Candidature of the applicant is liable to be cancelled if any discrepancy is found in the documents submitted at any stage and legal action will be taken for the same.
8. No TA/DA will be admissible to appear for Written Exam/ Interview or both.
9. The maximum age limit for apply will be 62 years.
10. The selection of the candidate will be completely on the basis of Requisite Qualification, Requisite Experience and on the basis of merit list prepared after Written Exam/ Interview or both.
11. The Project Director, Jharkhand State AIDS Control Society, Ranchi reserves the right to cancel/ postpone the recruitment wholly or partially if so required. No claim will be admissible in case of such cancellation/ postponement.
12. The application form made available by offline/postal/hand/any other mode shall not be entertained and summarisely rejected.
13.A non-refundable application fee for all Category is Rs.1,000/-(One Thousand rupees only) through online payment Gateway.
14. Disabled candidates (with at least 40% disability) are exempted from examination fees.
15. Candidates wish to apply for more than one post will have to submit separate application along with application fee.
16. All disputes will subject to the jurisdiction of Hon’ble High Court, Jharkhand.
17. the Last date of receiving the online application is 02/11/2020 till 05.00 pm.
18. The Decision of the Society in any matter relating to the recruitment at any stage of the recruitment process will be final and binding upon the candidates. No correspondence or personal queries in this regard shall be entertained.
Download Notification
for the Recruitment Portal User’s Manual click here.
0 notes
Text
Covid19 update: Blood Collection Market Witness Growth | QIAGEN N.V., F.L. Medical SR
Blood Collection Market analysts and researchers have done extensive analysis of the global Blood Collection market with the help of research methodologies such as PESTLE and Porter’s Five Forces analysis. The worldwide blood collection market is by leading companies such as Abbott Laboratories, Inc., Medtronic Plc., Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, QIAGEN N.V., F.L. Medical SRL,
The Global Blood Collection Market accounted to USD 150.4 million in 2017 growing at a CAGR of 6.4% during the forecast period of 2018 to 2025.
This Research will help you grow your Business: [Download free Sample PDF of This Research Report]
Major Market Drivers and Restraints:
Constant increase in Accidents and trauma cases
Emergence of liquid biopsy tests
Increasing demand of blood components
High cost of blood automated devices
Lack of skilled professionals in the market
Blood collection is the process of taking blood samples from the donor to performing laboratory diagnostic tests and in the treatment of patients. It is a crucial part of the blood management procedure in hospitals and blood banks centers.
By Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), By Method (Manual, Automated), By Application (Diagnostics, Treatment), By End User (Hospital, Blood Bank Center, Academics, Home Care)
Table of Contents
1 Market Overview
2 Manufacturers Profiles
3 Global Blood Collection Market Competitions, by Manufacturer
4 Global Blood Collection Market Analyses by Regions
5 North America Blood Collection by Countries
6 Europe Blood Collection by Countries
7 Asia-Pacific Blood Collection by Countries
8 South America Blood Collection by Countries
9 Middle East and Africa Blood Collection by Countries
10 Global Blood Collection Market Segment by Type
11 Global Blood Collection Market Segment by Application
12 Sales Channel, Distributors, Traders and Dealers
13 Research Findings and Conclusion
14 Appendixes
Enquire Here to Get Customization, Methodology & Check Discount for this Report @ CLICK HERE NOW
Important Features that are under offering & key highlights of the report:
Detailed overview of Blood Collection market
In-depth market segmentation by Type, Application etc.
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape of Blood Collection market
Strategies of key players and product offerings
Market player’s information to sustain and enhance their footprint
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards Blood Collection market performance
Changing market dynamics of the industry
Key questions answered
Who are the Leading key players and what are their Key Business plans in the Global Blood Collection market?
What are the key concerns of the five forces analysis of the Global Blood Collection market?
What are different prospects and threats faced by the dealers in the Global Blood Collection market?
What are the strengths and weaknesses of the key vendors?
Buy the Latest Detailed Report @ CLICK HERE NOW
Reasons for Buying this Blood Collection Report
1. Blood Collection market report aids in understanding the crucial product segments and their perspective.
2. Initial graphics and exemplified that a SWOT evaluation of large sections supplied from the Blood Collection industry.
3. Even the Blood Collection economy provides pin line evaluation of changing competition dynamics and retains you facing opponents.
4. This report provides a more rapid standpoint on various driving facets or controlling Blood Collection promote advantage.
5. This worldwide Blood Collection report provides a pinpoint test for shifting dynamics that are competitive.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report @
Global Banana Flour Market
Global Banana Powder Market
Global Barbeque Sauce Market
Global Batter and Breader Premixes Market
0 notes
Photo
Blood Test Collection at Home
SRL Diagnostic Lab offers you Blood test sample collection at home. They are professionals and provide accurate reports. They will be at your door step a cording to your convenience.
0 notes
Last Seen Blogs
entoncescomo
Sin título
anticapitalist-psd
anticapitalist-psd
hasilhkhariinicpxb622-blog
situs togel singapore hari ini indo
putariablack
casal novato